Lista de obras -

A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography

article

Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis

artículo científico publicado en 2017

Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition

artículo científico publicado en 2010

BRCA1 Mutation and Young Age Predict Fast Breast Cancer Growth in the Dutch, United Kingdom, and Canadian Magnetic Resonance Imaging Screening Trials

article

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study

artículo científico publicado en 2010

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

artículo científico publicado en 2012

Choices for women at risk of hereditary breast cancer

artículo científico publicado en 2013

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk

scientific article published on 30 July 2020

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging

artículo científico publicado en 2013

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study

artículo científico publicado en 2016

Hereditary breast cancer growth rates and its impact on screening policy

artículo científico publicado en 2005

Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy

scientific article published on 14 January 2014

MARIBS study

scientific article published on 01 July 2005

MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial

artículo científico publicado en 2019

Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis

artículo científico publicado en 2014

Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models

artículo científico publicado en 2016

Preoperative Breast MRI Can Reduce the Rate of Tumor-Positive Resection Margins and Reoperations in Patients Undergoing Breast-Conserving Surgery ⬇️

artículo científico publicado el 1 de febrero de 2013

Preoperative prediction of cosmetic results in breast conserving surgery

artículo científico publicado en 2014

Radioactive Seed Versus Wire-Guided Localization for Ductal Carcinoma in Situ of the Breast: Comparable Resection Margins

artículo científico publicado en 2020

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study

artículo científico publicado en 2014

Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis

artículo científico publicado en 2019

Solving the preoperative breast MRI conundrum: design and protocol of the MIPA study

scientific article published on 06 May 2020

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

scientific article published on 13 July 2019

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).

artículo científico publicado en 2015

The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers

scientific article published on 24 April 2020

Lista de obras de

A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammography

Accuracy of screening women at familial risk of breast cancer without a known gene mutation: Individual patient data meta-analysis

Assessment of false-negative cases of breast MR imaging in women with a familial or genetic predisposition

BRCA1 Mutation and Young Age Predict Fast Breast Cancer Growth in the Dutch, United Kingdom, and Canadian Magnetic Resonance Imaging Screening Trials

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study

Breast density as indicator for the use of mammography or MRI to screen women with familial risk for breast cancer (FaMRIsc): a multicentre randomized controlled trial

Choices for women at risk of hereditary breast cancer

Cost-effectiveness of Breast Cancer Screening With Magnetic Resonance Imaging for Women at Familial Risk

Cost-effectiveness of screening women with familial risk for breast cancer with magnetic resonance imaging

Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study

Hereditary breast cancer growth rates and its impact on screening policy

Lower mitotic activity in BRCA1/2-associated primary breast cancers occurring after risk-reducing salpingo-oophorectomy

MARIBS study

MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial

Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis

Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models

Preoperative Breast MRI Can Reduce the Rate of Tumor-Positive Resection Margins and Reoperations in Patients Undergoing Breast-Conserving Surgery ⬇️

Preoperative prediction of cosmetic results in breast conserving surgery

Radioactive Seed Versus Wire-Guided Localization for Ductal Carcinoma in Situ of the Breast: Comparable Resection Margins

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study

Should women with a BRCA1/2 mutation aged 60 and older be offered intensified breast cancer screening? - A cost-effectiveness analysis

Solving the preoperative breast MRI conundrum: design and protocol of the MIPA study

Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC).

The supplemental value of mammographic screening over breast MRI alone in BRCA2 mutation carriers

[Curative resection of a solitary clavicular metastasis]